CAS: 328543-09-5; Ag14361
- 英文名称Ag14361
- 中文名称AG 14361; 2-[4-[(二甲基氨基)甲基]苯基]-5,6-二氢咪唑并[4,5,1-jk][1,4]苯并二氮杂卓-7(4H)-酮
- IUPAC名称1-(4-((dimethylamino)methyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one.
- CAS编号328543-09-5
- MFCD编号:MFCD18385009
- FDA UNII编号:48N0U0K50I
- 分子式:C19H20N4O分子量:320.394
- 产品CID: 1320774
- 产品分类生物化工 → 抑制剂 → DNA损伤(DNA Damage)
物理性质
- 熔点216-218°C
- 密度1.27
- pKa:14.05±0.20(预测)
- PSA:53.65
- LogP:2.5187
- 溶解性不溶于水；温和加热和超声波下,乙醇中≥10.14 mg/mL； DMSO 中≥16 mg/mL
- 外观形态固体-粉末
- 储存条件Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
- 产品应用该化合物是KI < 5 NMOL/L的PARP-1抑制剂.AG14361至少比苯并胺强1000倍.AG14361的IC50在可稳定 SW620 单元格中为29 NM,在完好的SW622 单元格中有14 NM.
MSDS等安全信息
上下游产品
dimethyl amine 4-(6-oxo-6,7,8,9-tetrahydro-2,7,9a-triaza-benzo[cd]azulen-1-yl)-benzaldehyde 2-bromo-3-nitro-benzoic acid methyl ester terephthalaldehyde mono(diethylacetal)合成工艺路线路线简述
📜2-溴-3-硝基苯甲酸甲酯置于palladium On Activated Charcoal 盐酸,硫酸,氢气,Sodium Cyanoborohydride,Sodium Hydrogensulfite,溶剂黄146,Zinc(II) Chloride体系中,用 甲醇,乙醇,N,N-二甲基乙酰胺,水,乙酸乙酯 作为反应溶剂,100.0 °C,344.75 Kpa 条件下,反应 11.5H,反应生成 Ag 14361; 2-[4-[(二甲基氨基)甲基]苯基]-5,6-二氢咪唑并[4,5,1-Jk][1,4]苯并二氮杂卓-7(4H)-酮
参考文献:Tricyclic Benzimidazoles As Potent Poly(Adp-Ribose) Polymerase-1 Inhibitors
标题:Tricyclic Benzimidazoles As Potent Poly(Adp-Ribose) Polymerase-1 Inhibitors
摘要:Novel Tricyclic Benzimidazole Carboxamide Poly(Adp-Ribose) Polymerase-1 (Parp-1) Inhibitors Have Been Synthesized. Several Compounds Were Found To Be Powerful Chemopotentiators Of Temozolomide And Topotecan In Both A549 And Lovo Cell Lines. In Vitro Inhibition Of Parp-1 Was Confirmed By Direct Measurement Of Nad(+) Depletion And Adpribose Polymer Formation Caused By Chemically Induced Dna Damage.
DOI:10.1021/jm0255769
海关参考信息
- 2912110000-甲醛
2912210000-苯甲醛
2924199090-其他无环酰胺
2921199090-其他无环单胺 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2025241878-A1
优先权日:2022-01-24
标题:Tyrosine and resveratrol derivatives as novel modulators of cellular serine adp-ribosylation
发明人：MATHEW SAJISH
权利人:UNIV SOUTH CAROLINA
摘要:Methods and compositions are described herein for modulating protein synthesis, especially monosome translation and DNA damage response, especially short-patch base excision repair (SP-BER), NHEJ and HR for treating a disorder. Compositions include a therapeutically effective amount of a tyrosine or a resveratrol derivative.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
主要参考文献
1: Gu W, Ge R, Zhu F, Li D, Liang R, Ge J, Wang Y, Li B, Qiu J. PARP-1 inhibitor-AG14361 suppresses acute allograft rejection via stabilizing CD4+FoxP3+ regulatory T cells. Pathol Res Pract. 2020 Aug;216(8):153021. doi: 10.1016/j.prp.2020.153021. Epub 2020 May 21. 434(7035):913-7. doi: 10.1038/nature03443. Erratum in: Nature. 2007 May 17;447(7142):346. 10(3):881-9. doi: 10.1158/1078-0432.ccr-1144-3. 96(1):56-67. doi: 10.1093/jnci/djh005. 11(23):8449-57. doi: 10.1158/1078-0432.CCR-05-1224. 28(6):832-42. doi: 10.1038/onc.2008.439. Epub 2008 Dec 8. Erratum in: Oncogene. 2023 Feb;42(7):546-547.
7: Vazquez-Ortiz G, Chisholm C, Xu X, Lahusen TJ, Li C, Sakamuru S, Huang R, Thomas CJ, Xia M, Deng C. Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells. Breast Cancer Res. 2014 Jun 24;16(3):R67. doi: 10.1186/bcr3682.
8: Leak RK, Zhang L, Luo Y, Li P, Zhao H, Liu X, Ling F, Jia J, Chen J, Ji X. Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury. Stroke. 2013 Apr;44(4):1124-34. doi: 10.1161/STROKEAHA.111.680157. Epub 2013 Feb 21.
合成参考文献
参考文献:10.1158/1078-0432.ccr-05-1224
摘要:Smith LM, Willmore E, Austin CA, Curtin NJ. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks. Clin Cancer Res. 2005 Dec 01;11(23):8449–57. doi: 10.1158/1078-0432.ccr-05-1224.
📝 需求与反馈
尽可能描述清楚需求与问题信息
